期刊文献+

急性心肌梗死早期血清和肽素、肌钙蛋白的变化及其临床意义 被引量:7

下载PDF
导出
摘要 急性心肌梗死(acute myocardial infarction,AMI)的发病率逐年增加,早期诊治能有效挽救濒死心肌、降低AMI的病死率及病残率。目前诊断AMI的主要依据是临床胸痛症状、心电图改变以及心肌损伤标志物的增高。因部分患者心电图早期无特异性改变,检测心肌标志物在AMI诊断中起着重要作用,国内外的研究认为肌钙蛋白(cTn)是目前用于诊断心肌损伤较好的确定标志物,但肌钙蛋白Ⅰ(cTnⅠ)在AMI 6 h后才出现增高。寻找早期诊断AMI的标志物是当前研究的热点问题。
出处 《第三军医大学学报》 CAS CSCD 北大核心 2013年第21期2382-2383,共2页 Journal of Third Military Medical University
基金 贵阳市卫生局科学技术计划项目([2011]筑卫科技合同字第14号)
  • 相关文献

参考文献7

  • 1高润霖.急性心肌梗死诊断和治疗指南[J].中华心血管病杂志,2001,29(12):710-725. 被引量:4893
  • 2Szinnai G, Morgenthaler N G, Berneis K, et al. Changes in plasma eopeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects [ J ]. J Clin Endocrinol Metab, 2007, 92( 10): 3973-3978.
  • 3王晓,聂绍平,马长生.急性心肌梗死后延迟再灌注治疗的研究进展[J].临床心血管病杂志,2010,26(8):563-565. 被引量:4
  • 4Katan M, Morgenthaler N G, Dixit K C, et al. Anterior and posterior pituitary function testing with simultaneous insulin tolerance test and a novel copeptin assay [ J ]. J Clin Endocrinol Metab, 2007, 92 ( 7 ) : 2640- 2643.
  • 5Kelly D, Squire I B, Khan S Q, et al. C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction [ J ]. J Card Fail, 2008, 14(9) : 739 -745.
  • 6Keller T, Tzikas S, Zeller T, et al. Copeptin improves early diagnosis of acute myocardial infarction [ J ]. J Am Coil Cardiol, 2010, 55 (19) : 2096 - 2106.
  • 7Khan S Q, Dhillon O S, O' Brien R J, et al. C-terminal provasopres- sin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study[ J]. Circulation, 2007, 115 (16) : 2103 - 2110.

二级参考文献18

  • 1McNAMARA R L,WANG Y,HERRIN J,et al.Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction[J].J Am Coll Cardiol,2006,47:2180-2186.
  • 2KIM C B,BRAUNWALD E.Potential benefits of late reperfusion of infarcted myocardium.The open artery hypothesis[J].Circulation,1993,88(5 Pt 1):2426-2436.
  • 3ABBATE A,BUSSANI R,BIONDI-ZOCCAI G G,et al.Persistent infarct-related artery occlusion is associated with an increased myocardial apoptosis at postmortem examination in humans late after an acute myocardial infarction[J].Circulation,2002,106:1051-1054.
  • 4JUGDUTT B I.Ventricular remodeling after infarction and the extracellular collagen matrix:when is enough enough?[J].Circulation,2003,108:1395-1403.
  • 5NAKAGAWA M,TAKEMURA G,KANAMORI H,et al.Mechanisms by which late coronary reperfusion mitigates postinfarction cardiac remodeling[J].Circ Res,2008,103:98-106.
  • 6ABBATE A,BIONDI-ZOCCAI G G,BALDI A,et al.The 'Open-Artery Hypothesis':New Clinical and Pathophysiologic Insights[J].Cardiology,2003,100:196-206.
  • 7DZAVIK V,BEANLANDS D S,DAVIES R F,et al.Effects of late percutaneous transluminal coronary angioplasty of an occluded infarct-related coronary artery on left ventricular function in patients with a recent (《6 weeks) Q-wave acute myocardial infarction (total occlusion post-myocardial infarction intervention study[TOMIIS] -A pilot study)[J].Am J Cardiol,1994,73:856-861.
  • 8HORIE H,TAKAHASHI M,MINAI K,et al.Long-term beneficial effect of late reperfusion for acute anterior myocardial infarction with percutaneous transluminal coronary angioplasty[J].Circulation,1998,98:2377-2382.
  • 9YOUSEF Z R,REDWOOD S R,BUCKNALL C A,et al.Late intervention after anterior myocardial infarction:effects on left ventricular size,function,quality of life,and exercise tolerance:Results of the Open Artery Trial (TOAT Study)[J].J Am Coll Cardiol,2002,40:869-876.
  • 10HOCHMAN J S,LAMAS G A,BULLER C E,et al.Coronary intervention for persistent occlusion after myocardial infarction[J].N Engl J Med,2006,355:2395-2407.

共引文献4895

同被引文献64

  • 1柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2121
  • 2中华心血管病杂志编辑委员会.不稳定性心绞痛诊断和治疗建议中华医学会心血管病学分会[J].中华心血管病杂志,2000,(6):22-24.
  • 3Holwerda D A.A glycopeptide from the posteriorlobe of pig pituitaries I isolation and characterization[J].Eur J Bio- chem, 1972,28(3):334-339.
  • 4Preibisz JJ,Sealey JE,Laragh JH et al. Plasma and platelet vasopressin in essential hypertension and congestive heart failnre. Hypertension, 1983,5:1129-1138.
  • 5Morgenthaler NG,,Struck J, Bergmann Aet al. Assay for the measurement of vasopressin. Clin Chem, 2006,52(1): 112.
  • 6DunserMW, WenzelV, MayrAJ et al. Manage net of vasodilatory shock defining the role of arginine vasopressin. Drugs,2003,63:237-256.
  • 7GriebelG, Sternmelin J, GalCS et al. Non-pepfide vasopress in Vlb receptor antagonists as potential drugs for the treatment of stress-related disorders.Curt Pharm Des,2005,11:1549-1559.
  • 8Khan SQ, DhiUon QS, O' brien RJ, et al. C-Terminal provasopressin(copeptin) as a nocel and prognostic marker in acute myocardial infarction:Leicester acute myocardial infarction peptide(LAMP) study[J]. Circulation, 2007, 115:2103-2110.
  • 9Relchlin T, Hochholzer W, Stelzig C, et al. Incremental value of copeptin for rapid rule out of acute myocardial infarction[J].J Am Coll Cardiol,2009,54(1):60-68.
  • 10Keller T, Tzikas S, Zeller T, et al. Copeptin improces early diagonisis of acute myocardial infarction[J].J Am Coll Cardiol,2010, 55:2096-2106.

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部